Trademark Overview
On Wednesday, September 13, 2023, a trademark application was filed for TRIO with the United States Patent and Trademark Office. The USPTO has given the TRIO trademark a serial number of 98178586. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, August 29, 2024. This trademark is owned by SassyCam LLC. The TRIO trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Direct-to-consumer diagnostic test kits comprising a downloadable software application for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; scientific research specimen collection devices in the nature of cartridges and rigid and semi-rigid containers for the collection of saliva and bodily fluids for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; laboratory storage test cartridges used to store laboratory samples for use in analyzing microbiome, fertility, hormone, and biomarker testing of humans; medical laboratory research instruments for testing of bodily fluids and detecting the levels of biomarkers; downloadable software for health and medical data storage, data analysis, and report generation for analyzing microbiome, fertility, hormone, and biomarker information; downloadable software for recording, storing, and organizing cellular, molecular, physiological, and medical data for analyzing microbiome, fertility,...
Diagnostic at-home health test and screening kits comprised of medical diagnostic reagents for testing of bodily fluids for use in determining the presence of medical conditions and levels of biomarkers; diagnostic test cartridges in the nature of diagnostic test reagents for medical purposes for use in determining the presence of medical conditions and levels of biomarkers; direct-to-consumer diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in microbiome, fertility, hormone, and biomarker testing of humans; none of the aforesaid relating to thermal analysis and rheology instruments
Medical diagnostic testing, monitoring and reporting services, namely, providing testing, monitoring and reporting services using self-collected samples outside of a clinical laboratory setting; providing medical information in the field of microbiome, fertility, hormone, and biomarker testing of humans; none of the aforesaid relating to medical and clinical research in the field of oncology; none of the aforesaid relating to thermal analysis and rheology instruments
Direct-to-consumer medical diagnostic test kits comprised of probes, buffers, and reagents for use in microbial testing and microbiome, fertility, hormone, and biomarker testing of humans; medical testing apparatus, instruments, and devices for diagnostic use, namely, apparatus, instruments, and devices for medical diagnostic testing through the collection and analysis of body fluids, biomarkers, fertility, and hormone levels; medical instruments for taking samples for review for medical diagnostic purposes; lab test cartridges for medical testing purposes; medical devices, instruments, and apparatus for obtaining body fluid samples; saliva collection devices for medical purposes; sterile medical specimen collection tools in the nature of cartridges and rigid and semi-rigid containers for the collection of saliva and bodily fluids; none of the aforesaid relating to thermal analysis and rheology instruments
Providing scientific research information and analysis in the fields of microbiomes, fertility, hormone levels, and biomarkers; providing medical research information in the field of testing results for medical conditions; Software as a Service (SaaS) featuring software for health and medical data storage, data analysis, and report generation for medical diagnostic purposes; Software as a Service (SaaS) featuring software for recording, storing, and organizing cellular, physiological and molecular data for medical diagnostic purposes; Software as a Service (SaaS) featuring software for analyzing microbiome, fertility, hormone, and biomarker information for medical diagnostic purposes; Software as a Service (SaaS) featuring software for display and communication of medical information, remote patient monitoring and providing telehealth and digital medical services; none of the aforesaid relating to medical and clinical research in the field of oncology; none of the aforesaid relating to...